Pediatric anesthesia in the analgesic
Conditions
Interventions
Case series:remifentanil injection continuous intravenous infusion
Sponsors
Department of Anesthesiology, The 2nd Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
1 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1) ASA classification I to II class; (2) age from 1m to 12y old, male or female; (3) I, II group of cases (1m to 3y) select the operation time of 0.5 to 2 hours, the body surface, limbs, minor surgical procedures (such as tonsillectomy surgery, bilateral hernias, fractures closed nailing surgery); III, IV group of patients (3 to 12 years old) All ENT line tonsil and adenoidectomy in children; (4) agree to participate in this study, and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Anyone who had participated in other clinical trials four weeks ago; (2) A history of anesthesia; (3) ASA classification more than at least grade III; (4) large amount of bleeding more than 10ml/kg; (5) who are allergic to remifentanil or other opioids; (6) emergency children who can not make full preoperative preparation; (7) severe dehydration, electrolyte imbalance or shock in children; (8) liver and renal function was obviously abnormal (ie,the index is higher than the normal 2-fold or more); (9) bronchial asthma, neurological - muscular system diseases, malignant hyperthermia-prone children; (10) children with structural heart disease (such as sick sinus syndrome, atrioventricular block, etc.); (11) children with serious heart, lung or metabolic diseases; (12) children with neurological or psychiatric disorders, prolonged large doses of sedatives history; (13) premature children or low birth weight infants; (14) within 15 days of taking a monoamine oxidase inhibitor drug abusers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pressure;Heart Rate; | — |
Countries
China
Contacts
Public ContactQingquan Lian
Outcome results
None listed